Trials / Completed
CompletedNCT02533544
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B : a Real Life Multicenter Cohort Study in Korea
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 572 (actual)
- Sponsor
- Myeong Jun Song · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, single arm cohort study to see efficacy and safety of tenofovir disoproxil fumarate (TDF) in naïve chronic hepatitis B, retrospectively and prospectively both.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tenofovir disoproxil fumarate |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2015-08-27
- Last updated
- 2019-01-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02533544. Inclusion in this directory is not an endorsement.